Mar 5, 2020

Creation of an Open Science Dataset from PREVENT-AD, a Longitudinal Cohort Study of Pre-symptomatic Alzheimer′s Disease.

Jennifer Tremblay-Mercierthe PREVENT-AD Research Group


We describe the creation of an open science dataset from a cohort of cognitively unimpaired aging individuals with a parental or multiple-sibling history of Alzheimer′s disease (AD). Our purpose was to enable PResymptomatic EValuation of Novel or Experimental Treatments for AD (PREVENT-AD). To characterize this population, possibly progressing in the pre-symptomatic phase of AD, we studied genetic variants and obtained longitudinal measures of cognition, brain structure and function, blood and cerebral fluid biochemistry and neurosensory capacities. Two nested prevention trials were also conducted. Data were hosted in LORIS, a platform that facilitates data organization, curation and sharing. We initially assessed 425 individuals, 385 meeting criteria for sustained investigation and 330 remaining active for longitudinal follow-ups. Between 2011 and 2017, we obtained quality-controlled data from 1704 MRI scans, 532 CSF samples, and 1882 cognitive evaluations. To date, 310 active participants (94%) have agreed that their data be openly shared. In addition to being a living resource for continued data acquisition, therefore, PREVENT-AD offers shared data to facilitate understanding of AD pathogenesis.

  • References
  • Citations


  • We're still populating references for this paper, please check back later.
  • References
  • Citations


  • This paper may not have been cited yet.

Mentioned in this Paper

Congenital Sensorineural Hearing Loss
Physiologic Organization
Presymptomatic Testing
Granulocyte Colony-Stimulating Factor
Cognitive Aging
Alzheimer's Disease

Related Feeds

Alzheimer's Disease: Genes&Microglia (Preprints)

Genes and microglia are associated with the risk of developing and the progression of conditions such as Alzheimer's Disease (AD). Here are the latest preprints pertaining to this disease.

Alzheimer's Disease: Neuroimaging

Alzheimer's disease (AD) is a chronic neurodegenerative disease. Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Related Papers

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Justin MironPREVENT-AD Research Group
The Journal of Prevention of Alzheimer's Disease
J-M LeoutsakosJohn C S Breitner
The Medical Journal of Australia
Journal of Alzheimer's Disease : JAD
Miranda TuwaigPREVENT-AD Research Group
© 2020 Meta ULC. All rights reserved